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Bacterial pathogens cause a number of lethal diseases. Opportunistic bacterial
pathogens grouped into ESKAPE pathogens that are linked to the high degree of
morbidity, mortality and increased costs as described by Infectious Disease Society
of America. Acinetobacter baumannii is one of the ESKAPE pathogens which cause
respiratory infection, pneumonia and urinary tract infections. The prevalence of this
pathogen increases gradually in the clinical setup where it can grow on artificial surfaces,
utilize ethanol as a carbon source and resists desiccation. Carbapenems, a β-lactam, are
the most commonly prescribed drugs against A. baumannii. The high level of acquired
and intrinsic carbapenem resistance mechanisms acquired by these bacteria makes their
eradication difficult. The pharmaceutical industry has no solution to this problem. Hence,
it is an urgent requirement to find a suitable alternative to carbapenem, a commonly
prescribed drug for Acinetobacter infection. In order to do this, here we have made an
effort to review the active compounds of plants that have potent antibacterial activity
against many bacteria including carbapenem resistant strain of A. baumannii. We have
also briefly highlighted the separation and identification methods used for these active
compounds. This review will help researchers involved in the screening of herbal active
compounds that might act as a replacement for carbapenem.
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Introduction
Acinetobacter baumannii is a Gram-negative, non-motile, and non-fermentative coccus. It is
known to cause nosocomial infections such as urinary tract infections, surgical site infection,
meningitis, ventilator-associated pneumonia, bacteraemia, and very rarely intra-abdominal
infections and infections of skin and central nervous system (Zarrilli et al., 2009). Clinical report
showed that, the hospitalized patients who are infected with A. baumannii have about 30% chance
of mortality (Perez et al., 2007). Acinetobacter are usually found in the hospital environment and
infect patients who are hospitalized from a long period of time with severe underlying diseases,
are immunosuppressed, or subjected to invasive procedures and treated with broad-spectrum
antibiotics (Perez et al., 2007). These bacteria have been reported to colonize increasingly in the
respiratory tract of patients admitted in Intensive Care Unit. In case of non-intensive care unit
patients high rate of colonization of Acinetobacter strains are found on skin. During outbreaks
along with one or more epidemic Acinetobacter clones, there exists an endemic strain which makes
it difficult to identify and control their transmission (Marchaim et al., 2007; Oteo et al., 2007).
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A. baumannii have the ability to grow in diverse pH and
temperature conditions and utilizes many different kinds of
substrates for its growth (Tiwari and Tiwari, 2014). These
are known to survive in both dry and moist condition and
on inanimate objects like contaminated medical instruments
including ventilators, catheters, respirometers (Cunha et al.,
1980; Cefai et al., 1990; Horrevorts et al., 1995), pillows
(Weernink et al., 1995), bed mattresses (Sherertz and Sullivan,
1985) etc. They are found widely in water and soil and some of
them are also isolated from animals (Manchanda et al., 2010).
Numerous cases of worldwide outbreaks due to A. baumannii
depict increasing rates of resistance of these bacteria toward
commercially available antibacterial agents.
Multi-drug resistant A. baumannii have been reported to be
isolated from the hospitals in India (Tiwari et al., 2012; Tiwari
and Moganty, 2013, 2014; Tiwari and Tiwari, 2015), Turkey (Vila
et al., 2007), Taiwan (Lin et al., 2011), Argentina (Merkier and
Centron, 2006), Korea (Chaulagain et al., 2012), Japan (Endo
et al., 2012), Iran (Shahcheraghi et al., 2011), Saudi Arabia
(Alsultan et al., 2009), Latin America, North America, Europe,
Asia-Pacific rim (Mendes et al., 2010; Wang and Dowzicky,
2010), Brazil (Dalla-Costa et al., 2003; Gales et al., 2003; Sader
et al., 2005; Tognim et al., 2006; Villegas et al., 2007), many
countries of Asia and Middle-East (Afzal-Shah et al., 2001; Abbo
et al., 2005; Jeon et al., 2005; Jeong et al., 2006; Chan et al.,
2007; Ko et al., 2007; Koh et al., 2007), and also from Australia
and Pacific islands (Anstey et al., 1992, 2002; Riley et al., 1996;
Peleg et al., 2006; Iredell et al., 2007; Playford et al., 2007;
Valenzuela et al., 2007). Previous reports suggested that some
MDR strains of A. baumannii spread from regions of Spain
(Culebras et al., 2010), with high antibacterial resistance rates,
to regions like Norway, experiencing low rates of resistance. It
was also reported that the US military personnel and civilians
have received medical support in United Kingdom when they
were infected by theMDR strains, while posted in an operation in
Iraq and Afghanistan (Perez et al., 2007). Gradually since the late
1970s, cases of resistance started developing against most classes
of drugs. In the late 1990s, the only effective therapeutic option
left was carbapenem. In recent years, A. baumannii was also
found to become resistant to carbapenem making its treatment
more and more difficult. Various resistance mechanisms have
been acquired by A. baumannii against carbapenem (Manchanda
et al., 2010), such as presence of antimicrobial-inactivating
enzymes, i.e., β-lactamase (Brown et al., 2005; Chuang et al.,
2010; Rodriguez-Martinez et al., 2010; Acosta et al., 2011; Santella
et al., 2011), decreased access to bacterial targets (because of
reduced permeability of the outer membrane caused by loss of
or low porin expression, increased expression of multidrug eﬄux
pumps) (Fernandez-Cuenca et al., 2003; Wilke et al., 2005; Hu
et al., 2007; Vila et al., 2007; Vashist et al., 2010), and mutations
altering targets or different cellular functions. These mechanisms
may act in combination also for a single strain (Fernandez-
Cuenca et al., 2003; Rice, 2006).
Although no antibiotics with specific cellular targets have been
isolated from plants but modified plant natural antibiotics has
been more successful such as penicillin (Lewis and Ausubel,
2006). Attempts to develop potent antibiotics from plants have
failed by both pharmaceutical and biotech firms. A reason
for this may be the use of varying chemical strategy by
the plants to control bacterial infection, in order to reduce
the selective pressure for developing resistance to antibiotics.
For instance, antibacterial active compounds may act quite
effectively in combinations and have little potency alone. Plant
alkaloid berberine has excellent antibacterial properties but it
is ineffective when acting alone as it is a preferred substrate
of bacterial encoded MDRs (multidrug resistance pumps). 5′-
methoxyhydnocarpin, a compound isolated from the same plant
as berberine blocks the MDRs and therefore enabling berberine
to act as a potent antibacterial agent in presence of this
compound. So it is very necessary to first identify the antibacterial
mechanism of the plants and then screen pharmaceutically to
develop some effective antibiotic (Lewis and Ausubel, 2006).
Since there is no new development of antibiotics against
the carbapenem resistant strains of A. baumannii therefore,
it is necessary to focus on the antimicrobial activity of plant
derived substances that are being used in traditional medicine
worldwide (Savoia, 2012). Secondary metabolites are responsible
for the antimicrobial activity of plants. In this present review,
we have explained the various herbal active compounds which
have potent activity against A. baumannii and other Gram-
negative bacteria. This will initiate the search for new antibiotics
from herbal origin against the resistant strains of Acinetobacter
baumannii and this may lead to the development of new
antibiotics.
Extraction of Plant Active Compounds and
its Identification
Numerous works have been done to isolate and characterize
bioactive compounds from plant resources that are active against
Gram-positive and Gram-negative bacteria, fungi and viruses.
Miyasaki reported that generally flavones, tannins and phenolic
compounds are known to be active against Acinetobacter
(Miyasaki et al., 2013). Many active herbal compounds have
been isolated and reported for their activities. These secondary
metabolites were extracted using different solvents such as
methanol, ethanol, water, hydroxide, acetone, and through
various techniques like HPLC, column chromatography
from plant materials. After extraction of the plant materials,
elucidation of the active metabolites and their structures
were performed by different methods. The methods include
GC-MS (gas chromatography-mass spectrometer), LC-MS
(liquid chromatography-mass spectrometer), and NMR (nuclear
magnetic resonance).
The efficiency for separating and identifying compounds from
complex biological mixture is very high for GC-MS (Villas-
Boas et al., 2005). It is capable of simultaneously identifying
and profiling several compounds that possess different functions.
This is mostly used for making the fingerprints of compounds
that are volatile in nature which somewhat make the analyzing
process repetitive and time consuming (Formisano et al., 2012;
Huang et al., 2012; Wang et al., 2012). GC-MS can be used for
compounds having lower molecular mass and that are volatile
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or semi volatile in nature (Villas-Boas et al., 2005; Dunn et al.,
2011). Here, the capillary column has a low flow rate, so that
output of the column can be directly put to MS ionization
chamber (Oleszek and Marston, 2000; Phillipson, 2007; Daffre
et al., 2008). Besides GC-MS, another most important analytical
technique is LC-MS where liquid chromatography is coupled
to mass spectrometry along with electrospray ionization and
atmospheric pressure chemical ionization (Villas-Boas et al.,
2005). It can identify and analyze a large number of compounds,
present in small quantities whose molecular mass vary from
10 to 300,000 with varying chemical properties (Hagel and
Facchini, 2008). As compared to GC-MS, sample preparation
is quite simple in case of LC/MS (Dunn and Ellis, 2005). By
LC/MS analysis, high resolution mass accuracy can be achieved
which is important for analyzing herbal active compounds. This
property is enhanced by the use of ultra-performance liquid
chromatography. It can also be said that LC-MS is more preferred
over GC-MS in reducing time andmoney for sample preparation.
NMR spectra provide great information about the structures of
the compounds along with their identification via interpretation
of spectra involving chemical shift and chemical constants. It
is quantitative, reproducible, non-sample destructive, and non-
specific which makes it superior to other analytical techniques
(Dunn et al., 2011).
The antibacterial components of various plants, their
separation and identification techniques are listed below in
Table 1. Some of these herbal compounds have the ability to work
alone or in presence of the other, i.e., in synergy which are also
explained in Table 1.
Plant Active Compounds against
Gram-Negative Bacteria
The antibacterial components of various plants were screened
against a wide range of Gram-positive as well as Gram-negative
bacteria mostly by MIC, disk diffusion assay and CFU. It
was found that some of the compounds were more active
against Gram-positive whereas some were more active against
Gram-negative bacteria. The Gram-positive bacteria that are
tested against different active compounds of plants include
Staphylococcus aureus, Bacillus cereus, Helicobacter pylori,
Salmonella enteritidis, and Clostridium jejuni (see Table 2). The
Gram-negative bacteria like Klebsiella pneumoniae, Enterobacter
aerogenes, Providencia stuartii, Escherichia coli, Enterobacter
cloacae, and Pseudomonas aeruginosa are susceptible toward the
active compounds of Hibiscus subdarifa, L. salicaria, Adansonia
digitata, Commiphora molmol, etc. (see Table 2).
Plant Active Compounds against
Acinetobacter baumannii
This study is aimed to review the literature regarding
herbal active compounds against various bacteria, including
Acinetobacter baumannii. Hence, we have listed most of the
plants in Table 2, which are reported to inhibit this pathogen
by varying mechanisms. L. salicaria shows significant activity
against different bacteria but, especially A. baumannii and
P. aeruginosa. Hence its topical form may be used to treat
infections of skin and soft tissue (antiseptic), infections of burn
wounds, diabetic foot and decubitus wound caused by these
MDR bacterial strains. It is already known that this plant has
been used as traditional medicine for many indications, but to
use it clinically, several in vitro and in vivo test have to be
performed(Guclu et al., 2014).
Saulnier et al. used essential oils of herbs like Syzygium
aromaticum, Cinnamomum zeylanicum, and Thymus in
nano medicine against multidrug-resistant A. baumannii.
Cinnamaldehyde prevents the activity of amino acid
decarboxylase in the bacteria (Burt, 2004), but it is unable
to disorganize outer membrane of cell or deplete intracellular
ATP concentration. Hydroxyl group of carvacrol and eugenol
(phenolic compounds) can disrupt the bacterial cell wall. This
phenomenon has the potential to decrease intracellular ATP
pool and membrane potential (Ultee et al., 2002; Gill and Holley,
2006). It also results in the leakage of various substances such
as ATP, amino acids, ions, and nucleic acids ultimately leading
to bacterial death. MIC of active components is the same as
MIC of those compounds when nano-encapsulated. Lipidic
nanocapsules (LNC) can be made more effective by improving
their presence in systemic circulation through the modifications
on LNC surface. It can be a good alternative of antibiotics
(Saulnier, 2014).
Curcumin alone had very little antibacterial activity against A.
baumannii strains with high MIC (256µg/ml). The antibacterial
activity of curcumin is due to several reasons for instance,
disruption of folic acid metabolism (shikimate dehydrogenase)
pathway (De et al., 2009) and bacterial cell division (Rai et al.,
2008). Combinatorial use of curcumin and epigallocatechin
gallate (EGCG) is very much effective in increasing the inhibition
level by many folds, making the MIC 4µg/ml. This study
indicates synergistic effects to prevent A. baumannii growth
between curcumin and EGCG without any antagonistic effects
(Betts and Wareham, 2014). In the same way epicatechin, a
tea polyphenol having no antibacterial properties can potentiate
theaflavin, increasing its activity against A. baumannii and
S. maltophilia isolates. The probable mechanism may be that
epicatechin inhibits theaflavin oxidation thus enhancing its
antibacterial effect, but the exact mechanism of synergy is not yet
understood and needs further study (Betts et al., 2011).
Khadri, et al. reported the presence of methyl allyl trisulfide
(34.61%) and diallyl disulfide (31.65%) with other compounds at
relatively lower levels after GC/MS analysis in Allium sativium. It
showed significant activity against P. aeruginosa in vitro and can
be used for treating infections caused by this pathogen (Khadri
et al., 2010). Aloe vera gel extract were reported to be more
active for Gram-positive than Gram-negative bacteria. Ethanol
extract was most active followed by methanol extract activity
and least inhibition was exhibited by acetone extract (Lawrence
et al., 2009). Magnolia dealbata extracts showed good inhibition
zone of>10mm against P. aeruginosa, Clavibacter michiganensis,
A. baumannii, A. iwoffii. Generally, the active constituents
of M. dealbata like honokiol and magnolol possess selective
antimicrobial activities against drug resistant Gram-negative
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TABLE 1 | Antibacterial components of plants with their extraction and identification methods.
Plant (Common name) Antibacterial compounds Extracted from Separation methods Identification
methods
References
Rosa rugosa (Japanese
rose)
Ellagic acid Dry powders of plant
extract
HPLC LC/MS, NMR Miyasaki et al.,
2013
Terminalia chebula
(Myrobalan/Hardad)
Chebulagic acid, Chebulinic
acid, Corilagin, and
Terchebulin
Dry powders of plant
extract
HPLC LC/MS, NMR Miyasaki et al.,
2013
Scutellaria baicalensis
(Baical skullcap)
Norwogonin, Baicalin, and
Baicalein
Dry powders of plant
extract
HPLC, Aqueous and
ethanolic extract
LC/MS, NMR Chan et al., 2011;
Miyasaki et al.,
2013
Lythrum salicaria (Purple
loosestrife)
Hexahydroxy diphenoyl
ester vescalagin
Flowers and leaves Methanolic extract,
Column
chromatography
N/A Becker et al.,
2005; Guclu et al.,
2014
Syzygium
aromaticuma,b (Clove)
Eugenol Essential leaf oil Hydroxide solution
extraction and
distillation
N/A Pelletier, 2012;
Saulnier, 2014
Cinnamomum
zeylanicuma,b
(Cinnamon/Dalchini)
Trans-cinnamaldehyde Essential leaf oil N/A N/A Pelletier, 2012;
Saulnier, 2014
Oreganum vulgarea,b
(Oregano)
Carvacrol Essential leaf oil N/A N/A Pelletier, 2012;
Saulnier, 2014
Thymusb (Common
thyme/Garden thyme)
Thymol Essential leaf oil N/A N/A Pelletier, 2012
Curcuma longac
(Turmeric/Haldi)
Curcumin Plant extract powder Methanolic extract N/A Betts and
Wareham, 2014
Camellia sinensisc,d (Green
tea)
Epigallocatechingallate,
epicatechin
Plant extract powder Ethanolic extract N/A Betts et al., 2011;
Betts and
Wareham, 2014
Camellia sinensisd (Black
tea)
Theaflavin Plant extract powder Ethanolic extract N/A Betts et al., 2011
Lycium chinense Mill.
(Cortex lycii/Wolfberry)
(+)-Lyoniresinol-3 alpha-O-
beta-D-glucopyranoside
Herbal materials Aqueous and ethanolic
extract
N/A Chan et al., 2011
Paeonia suffruticosa Andr.
(Cortex moutan)
Paeonol Herbal materials Aqueous and ethanolic
extract
N/A Chan et al., 2011
Coptidis chinensis Franch.
(Rhizoma coptidis)
Berberine Herbal materials Aqueous and ethanolic
extract
N/A Chan et al., 2011
Berberis fremontii (Desert
barberry)
Berberine Leaves Hexane extract NMR, MS Stermitz et al.,
2000; Lewis and
Ausubel, 2006
Hydrastis Canadensis
(Goldenseal)
Berberine Aerial parts Aqueous and ethanolic
extract
LC-MS Lewis and
Ausubel, 2006;
Ettefagh et al.,
2011
Azadirachta indica (Neem) stigmasterol, nimbiol, sugiol,
4-cymene, α-terpinene,
terpinen-4-ol
Leaves, bark Methanolic extract GC-MS Nand et al., 2012
(Continued)
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TABLE 1 | Continued
Plant (Common name) Antibacterial compounds Extracted from Separation methods Identification
methods
References
Aloe vera (Indian aloe, Ghi
Kunvar)
p-coumaric acid, ascorbic
acid, pyrocatechol cinnamic
acid
Leaves ethanol, methanol and
acetone extracts, thin
layer and column
chromatography
GC-MS Lawrence et al.,
2009
Allium sativum (Garlic) allyl methyl disulfide,
diallylsulfide, diallyltrisulfide,
allyl methyl trisulfide, diallyl
disulfide
Bulbs HPLC GC-MS Khadri et al., 2010;
Lu et al., 2011
Magnolia dealbata
(Cloudforest magnolia)
Honokiol, magnolol Seeds Ethanolic extract N/A Jacobo-Salcedo
Mdel et al., 2011
Rabdosia rubescens
(Blushred rabdosia)
phaeophytin a, phaeophytin
b,
17c-ethoxypheaophorbide
a, 17c-ethoxyphea
ophorbide b, oleanolic acid,
physcion, emodin-8-O-
beta-D-glucopyranoside,
isorhamnetin
N/A ODS column
chromatography
NMR and MS Lv and Xu, 2008
aSyzygium aromaticum, Cinnamomum zeylanicum, Oreganum vulgare shows synergism.
bSyzygium aromaticum, Cinnamomum zeylanicum, Oreganum vulgare and Thymus shows synergism.
cCurcuma longa and Camellia sinensis (Green tea) exhibits synergism.
dCamellia sinensis (Green tea) and Camellia sinensis (Black tea) exhibits synergism.
bacterial species and fungal pathogens (Jacobo-Salcedo Mdel
et al., 2011).
Miyasaki et al. (2013) suggested in their studies, norwogonin
(5,6,7-trihydroxyflavone) extracted from Scutellaria baicalensis,
has an MIC90 of 128µg/ml against some strains of A.
baumannii. Chebulagic acid, chebulinic acid (65% inhibition at
62.5µg/ml), ellagic acid (67% inhibition at 250µg/ml), corilagin,
and terchebulin extracted from Terminalia chebula had lower
activity against A. baumannii in vitro. Other constituents of
Scutellaria baicalensis, baicalin and baicalein are also found to
be active against other bacteria. Corilagin, chebulagic acid, and
terchebulin of Terminalia chebula exhibits a two-step killing
kinetic. The medical literature reported that many phenolic
compounds of plant extracts enhance the potential of synthetic
antibiotics against A. baumannii in vitro (Miyasaki et al., 2013).
For instance, activity of rifampicin, coumermycin, fusidic acid,
novobiocin, and chlorobiocin was enhanced by tannic acid
and ellagic acid against A. baumannii in vitro (Chusri et al.,
2009). Even synergy was observed between topical mafenide and
green tea polyphenol against multi-drug resistance Acinetobacter
baumannii in-vitro (Osterburg et al., 2009), while no effect of
synergy was noted between any antibiotics for Gram-negative
bacteria and norwogonin.
Some Chinese medicines extracted from different plants
have been reported to exhibit significant antibacterial activities.
The active constituent of Rhizoma coptidis is berberine, an
alkaloid possessing various antimicrobial activities. Berberine is
also isolated from Berberis fremontii and Hydrastis canadensis
(Lewis and Ausubel, 2006) It has anti-Herpes simplex virus
effects and at moderate concentrations (30–45µg/ml) sufficient
antibacterial effect was observed along with inhibition of biofilm
formation. Plant derived antibacterial molecule are generally
weak but work better in synergy with antibiotics (Lewis and
Ausubel, 2006). Synergism was also seen for berberine and β-
lactam antibiotics against multi drug resistant S. aureus. (+)-
Lyoniresinol-3 alpha-O-beta-D-glucopyranoside of Cortex Lycii
presented strong antimicrobial effect against multi drug resistant
S. aureus isolated from patients and some pathogenic fungi, but
it did not cause any haemolysis on human RBCs. This also
possesses potent antifungal activities against Candida albicans.
There is very limited literature concerned with the antibacterial
effects of CortexMoutan. The ethanolic extract of CortexMoutan
suppress the growth of S. aureus (Chan et al., 2011). Only paeonol
is identified as active ingredients till date, which is responsible
for its anti-microbial effects on C. albicans, C. tropicalis, and C.
glabrata etc. (Chan et al., 2011).
A very common medicinal plant A. indica is the source
of various active compounds identified by GC/MS analysis
possessing versatile effects like anti-bacterial, anti-inflammatory,
antioxidant activities (Nand et al., 2012). Hence further studies
can be performed to see its activity against Gram-negative
bacteria and especially A. baumannii.
Conclusion and Future Prospects
Emergence of resistant strains of bacterial pathogens is a major
source of high morbidity, mortality, and increased cost, making
its treatment much more difficult. Traditionally, plants play
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TABLE 2 | List of bacteria susceptible to the bioactive herbal components.
Active compounds Source Antibacterial assay
method
Active against bacteria MIC (µg/ml) References
Hexahydroxy diphenoyl
ester vescalagin
Lythrum salicaria Agar well diffusion test A. baumannii N/A Becker et al., 2005;
Guclu et al., 2014H. pylori N/A
P. aeruginosa N/A
Staphylococcus aureus 62
B. cereus N/A
Mycobacterium smegmatis N/A
Micrococcus luteus 125
Proteus mirabilis 62
Ellagic acid Rosa rugosa MIC, MBC A. baumannii 250 Miyasaki et al., 2013
Terchebulin Terminalia chebula MIC, MBC A. baumannii 500 Miyasaki et al., 2013
Chebulagic acid 1000
Chebulinic acid 62.5
Corilagin 1000
Norwogonin Scutellaria
baicalensis
MIC, MBC A. baumannii 128 Chan et al., 2011;
Miyasaki et al., 2013Baicalin N/A
Baicalein N/A
Eugenol Syzygium
aromaticum
MIC, CFU A. baumannii 1250 Kollanoor Johny et al.,
2010; Pelletier, 2012;
Saulnier, 2014
C. jejuni N/A
S. enteritidis N/A
Trans-cinnamaldehyde Cinnamomum
zeylanicum
MIC, CFU A. baumannii 310 Kollanoor Johny et al.,
2010; Pelletier, 2012;
Saulnier, 2014
CFU S. enteritidis N/A
CFU C. jejuni N/A
Carvacrol Oreganum vulgare MIC, CFU Biofilms of Staphylococcus
epidermidis
0.031%, v/v Nostro et al., 2007;
Kollanoor Johny et al.,
2010; Pelletier, 2012;
Saulnier, 2014
Biofilms of S. aureus 0.015–0.031%, v/v
A. baumannii 310
S. enteritidis N/A
C. jejuni N/A
Thymol Thymus CFU, MIC S. enteritidis N/A Nostro et al., 2007;
Kollanoor Johny et al.,
2010; Pelletier, 2012
C. jejuni N/A
A. baumannii N/A
S. epidermidis biofilms 0.031%, v/v
biofilms of S. aureus 0.031–0.062%, v/v
Curcumin Curcuma longa MIC, time kill assay, FIC
index, CFU
S. aureus 125–250 De et al., 2009; Hu
et al., 2013; Mun et al.,
2013; Betts and
Wareham, 2014
H. pylori 5–50
A. baumannii 4 (in presence of
EGCG)
Streptococcus mutans 175
Epigallocatechin gallate
(EGCG)
Camellia sinensis
(Green tea)
MIC, time kill assay, FIC
index, CFU
S. aureus 100 Kono et al., 1997; Zhao
et al., 2002; Osterburg
et al., 2009; Gordon
and Wareham, 2010;
Betts and Wareham,
2014
A. baumannii 312–625
Stenotrophomonas
maltophilia
512
H. pylori 64
Epicatechin Camellia sinensis
(Green tea)
Disk diffusion assay A. baumannii N/A Betts et al., 2011
S. maltophilia N/A
(Continued)
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TABLE 2 | Continued
Active compounds Source Antibacterial assay
method
Active against bacteria MIC (µg/ml) References
Theaflavin Camellia sinensis
(Black tea)
Disk diffusion assay A. baumannii N/A Betts et al., 2011
S. maltophilia N/A
(+)-Lyoniresinol-3
alpha-O-beta-D-
glucopyranoside
Lycium chinense
Mill.
CFU A. baumannii N/A Chan et al., 2011
S. aureus N/A
Enterococcus faecalis N/A
Paeonol Paeonia
suffruticosa Andr.
CFU A. baumannii N/A Chan et al., 2011
S. aureus N/A
E. faecalis N/A
Berberine Coptidis chinensis
Franch.
CFU A. baumannii N/A Chan et al., 2011
S. aureus N/A
E. faecalis N/A
Berberine Berberis fremontii
(Desert barberry)
MIC S. aureus 30 Stermitz et al., 2000;
Lewis and Ausubel,
2006
Berberine Hydrastis
Canadensis
(Golden seal)
CFU, FIC S. aureus, Streptococcus
pyogenes
N/A Lewis and Ausubel,
2006; Ettefagh et al.,
2011
Honokiol, Magnolol Magnolia dealbata Disk diffusion assay Clavibacter michiganensis,
P. aeruginosa, A. baumannii,
Acinetobacter iwoffii
N/A Jacobo-Salcedo Mdel
et al., 2011
α-elemene, δ-elemene,
furanosesquiterpenes
Commiphora
molmol (Myrrh)
Disk diffusion assay,
CFU, MIC
K. pneumoniae 6250 Masoud and Gouda,
2012P. aeruginosa 6250
A. baumannii 2500
E. coli 6250
p-Coumaric acid,
ascorbic acid,
pyrocatechol, cinnamic
acid
Aloe vera Agar well Diffusion
Technique
S. aureus, Streptococcus
pyogenes, B. subtilis,
Bacillus cereus, E. coli, P.
aeruginosa, K. pneumonia,
Salmonella typhi
N/A Lawrence et al., 2009
Allyl methyl disulfide,
Diallylsulfide,
Diallyltrisulfide, Allyl
methyl trisulfide,
Diallyldisulfide,
Diallyltetrasulfide
Allium sativum
(Garlic)
MIC P. aeruginosa 3120 Khadri et al., 2010; Lu
et al., 2011
K. pneumonia 1250
A. baumannii 3120
CFU C. jejuni N/A
Stigmasterol, Nimbiol,
sugiol,4-cymene,
α-terpinene,
terpinen-4-ol
Azadirachta indica Disk diffusion assay S. epidermidis N/A Fabry et al., 1998;
Nand et al., 2012MIC S. aureus 1000
Enterococci 500
Klebsiella 2000
P. aeruginosa 1000
E. coli 2000
Salmonella 2000
Gossypetin, hibiscetin,
quercetin, sabdaretin,
delphinidin
3-O-sambubioside and
cyanidin
3-O-sambubioside
Hibiscus subdarifa
(Indian sorrel/Rose
mallow)
MIC, MBC K. pneumoniae 1024 Djeussi et al., 2013;
Pacôme et al., 2014E. aerogenes 1024
P. stuartii 512
E. coli 1024
E. cloacae 256
(Continued)
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TABLE 2 | Continued
Active compounds Source Antibacterial assay
method
Active against bacteria MIC (µg/ml) References
Quercetin-7-0-B-D-
xylopyranoside,
7-baueren-3-acetate
Adansonia digitata
(Baobab/Gorakh
imli)
MIC, MBC K. pneumoniae 1024 Djeussi et al., 2013
E. coli 1024
E. cloacae 1024
Providencia stuartii 1024
E. aerogenes 1024
MIC, Minimum Inhibitory Concentration; MBC, Minimum Bactericidal Concentration; FIC, Fractional Inhibitory Concentration; CFU, Colony Forming Units.
an important role in treatment of diseases, hence it may be
used as a source to find out alternative drug to carbapenem.
Plants possess secondary metabolites that are reported to be
potentially active against a wide variety of bacteria. It was
also found that the herbal compounds are weak antibacterials
but showed better antimicrobial activity when used in synergy
with other antibiotics. The advancement in the techniques
for separation, purification and identification of bioactive
compounds make it possible to chemically and structurally
identify these compounds. In present review, we have made an
effort to list a number of plant active compounds that may
have potent antibacterial activity against someGram-positive and
Gram-negative bacteria including carbapenem resistant strain
of A. baumannii. Hence, the use of different plant natural
compounds as antibacterial agents is an interesting strategy
for discovering bioactive products that could become useful
therapeutic tools. This review will help researchers involved in
the screening of herbal active compounds that might act as a
replacement for carbapenem, a β-lactam. In this review we found
a compound named norwogonin which has good antibacterial
activity (MIC90 – 128µg/ml) against A. baumannii. Hence,
special emphasis can be given on this compound in further
studies in order to use it as an alternative of carbapenem. Effect
of this compound on other bacteria can also be screened. There
are some plants shown inTable 2 that shows good activity against
many bacteria like Allium sativum, Adansonia digitata, Hibiscus
subdarifa, etc., have not been tested against A. baumannii.
Therefore, activities of these plants can also be tested against A.
baumannii. Screened herbal active compound may be tested in
the future for its antimicrobial activity. In-silico approach can also
be used to modify the structure of active compound for its better
antibacterial activity against carbapenem resistant strain of A.
baumannii. Potential plant active compound may be chemically
synthesized and used as an alternative to carbapenem.
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